These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25231823)

  • 1. [Prediction of Alzheimer's dementia].
    Jessen F; Dodel R
    Nervenarzt; 2014 Oct; 85(10):1233-7. PubMed ID: 25231823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical index to predict progression from mild cognitive impairment to dementia due to Alzheimer's disease.
    Lee SJ; Ritchie CS; Yaffe K; Stijacic Cenzer I; Barnes DE
    PLoS One; 2014; 9(12):e113535. PubMed ID: 25486250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of dementia and mild cognitive impairment in a Bulgarian urban population.
    Dimitrov I; Tzourio C; Milanov I; Deleva N; Traykov L
    Am J Alzheimers Dis Other Demen; 2012 Mar; 27(2):131-5. PubMed ID: 22495341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse.
    Blanc F; Mahmoudi R; Jonveaux T; Galmiche J; Chopard G; Cretin B; Demuynck C; Martin-Hunyadi C; Philippi N; Sellal F; Michel JM; Tio G; Stackfleth M; Vandel P; Magnin E; Novella JL; Kaltenbach G; Benetos A; Sauleau EA
    Alzheimers Res Ther; 2017 Jun; 9(1):47. PubMed ID: 28655337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.
    Biessels GJ; Despa F
    Nat Rev Endocrinol; 2018 Oct; 14(10):591-604. PubMed ID: 30022099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of dementia of Alzheimer type by different types of subjective cognitive decline.
    Jessen F; Kleineidam L; Wolfsgruber S; Bickel H; Brettschneider C; Fuchs A; Kaduszkiewicz H; König HH; Mallon T; Mamone S; Pabst A; Pentzek M; Roehr S; Weeg D; Jochen W; Weyerer S; Wiese B; Maier W; Scherer M; Riedel-Heller S; Wagner M
    Alzheimers Dement; 2020 Dec; 16(12):1745-1749. PubMed ID: 33140565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.
    Forlenza OV; Diniz BS; Teixeira AL; Stella F; Gattaz W
    Braz J Psychiatry; 2013; 35(3):284-94. PubMed ID: 24142092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the diagnosis of dementia.
    Eschweiler GW; Leyhe T; Klöppel S; Hüll M
    Dtsch Arztebl Int; 2010 Oct; 107(39):677-83. PubMed ID: 20963198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss as a predictor of dementia and Alzheimer's disease?
    Nourhashémi F; Vellas B
    Expert Rev Neurother; 2008 May; 8(5):691-3. PubMed ID: 18457525
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models for predicting risk of dementia: a systematic review.
    Hou XH; Feng L; Zhang C; Cao XP; Tan L; Yu JT
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):373-379. PubMed ID: 29954871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.